Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Inhibition of Protein Kinase Activity by Aptameric Action of Oligonucleotides

  • Read more about Inhibition of Protein Kinase Activity by Aptameric Action of Oligonucleotides
US Patent 5,998,596
Filed on 1995-04-04

BIFUNCTIONAL DTPA-TYPE LIGAND

  • Read more about BIFUNCTIONAL DTPA-TYPE LIGAND
US Patent 5,434,287
Filed on 1993-11-04

O6-SUBSTITUTED GUANINE COMPOSITIONS AND METHODS FOR DEPLETING THE O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

  • Read more about O6-SUBSTITUTED GUANINE COMPOSITIONS AND METHODS FOR DEPLETING THE O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
US Patent 5,691,307
Filed on 1994-06-07

DNA ENCODING A GROWTH FACTOR SPECIFIC FOR EPITHELIAL CELLS (KGF)

  • Read more about DNA ENCODING A GROWTH FACTOR SPECIFIC FOR EPITHELIAL CELLS (KGF)
US Application 08/106,775
Filed on 1993-08-16

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PROTEINS AS THERAPEUTIC AGENTS AND VACCINES IN THE TREATMENT AND PREVENTION OF ...

  • Read more about MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PROTEINS AS THERAPEUTIC AGENTS AND VACCINES IN THE TREATMENT AND PREVENTION OF ...
US Application 08/169,928
Filed on 1993-12-20

DOMINANT NEGATIVE DELETION MUTANTS OF C-JUN AND THEIR USE IN THE PREVENTION AND TREATMENT OF CANCER

  • Read more about DOMINANT NEGATIVE DELETION MUTANTS OF C-JUN AND THEIR USE IN THE PREVENTION AND TREATMENT OF CANCER
US Patent 6,699,842
Filed on 1994-03-10

Methods For Determining The Presence Of Functional p53 In Mammalian Cells

  • Read more about Methods For Determining The Presence Of Functional p53 In Mammalian Cells
US Patent 5,858,679
Filed on 1995-05-10

COMPOSITION AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER, AIDS AND ANEMIA

  • Read more about COMPOSITION AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER, AIDS AND ANEMIA
US Patent 5,635,532
Filed on 1993-10-12

NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY

  • Read more about NITRIC OXIDE RELEASING COMPOUNDS AS PROTECTIVE AGENTS IN ISCHEMIA REPERFUSION INJURY
US Application 08/146,610
Filed on 1993-11-02

METHOD OF TREATING RETROVIRAL INFECTION USING IL-12

  • Read more about METHOD OF TREATING RETROVIRAL INFECTION USING IL-12
US Application 08/173,498
Filed on 1993-12-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1596
  • Page 1597
  • Page 1598
  • Page 1599
  • Page 1600
  • Page 1601
  • Page 1602
  • Page 1603
  • Page 1604
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health